ePlaza Magazine
Submit news for free

Biotech Investors Fear Bezos More Than Trump as Costs Targeted

Investors in biotech may take little notice of the president’s criticisms of drug prices these days, but there are at least three men the industry still fears.

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More